APTIVIN is a combination of Cyproheptadine and Tricholine Citrate which belongs to the group of medicines called Antihistamines and Bile acid-binding agents respectively. It is indicated for loss of appetite, weight loss and anorexia nervosa (eating disorder). It is used as an adjunct to anti-tubercular and antiretroviral regimens for weight gain.
It is also used to treat allergic rhinitis (allergic reaction that causes sneezing, congestion, itchy nose and sore throat), conjunctivitis (inflammation or infection of the conjunctiva), migraine (recurrent throbbing headache that typically affects one side of the head), asthma (airways become inflamed, narrow and swell and produce extra mucus and it causes breathing difficulty) and hepatic disorders. In children, it is indicated to gain weight who have an inadequate dietary intake or loss of appetite and who suffer from anemia, liver or digestive disorder.
APTIVIN is not recommended for use in patients who have or had angle-closure glaucoma, stenosing peptic ulcer, symptomatic prostatic hypertrophy (enlarged prostate), bladder neck obstruction, and pyloroduodenal obstruction. Avoid consumption of alcohol during treatment with APTIVIN, as it may increase the risk of stomach problems. Before taking APTIVIN, inform your doctor if you have a history of bronchial asthma, increased intraocular pressure, hyperthyroidism, cardiovascular disease, liver or kidney problems and high blood pressure.
APTIVIN is not recommended for use in pregnant and breastfeeding women. It is recommended for use in children and adolescents (below 18 years of age) after doctor’s advice. The most common side effects of taking APTIVIN are drowsiness, dizziness, insomnia, blurred vision, loss of coordination, skin rash, gastrointestinal upset, nausea, or vomiting. Consult your doctor if any of the symptom worsens.